1996 - Paul Ehrlich and Ludwig Darmstaedter Prize
1993 - Robert Koch Prize
Hans-Georg Rammensee spends much of his time researching Immunology, Antigen, Cytotoxic T cell, Molecular biology and Major histocompatibility complex. His work carried out in the field of Immunology brings together such families of science as Pharmacology and In vivo. His Antigen research includes themes of Cancer research, Melanoma and T cell, Immune system, Immunotherapy.
He has included themes like Epidermal growth factor receptor, Immunosurveillance, Virology, Human cytomegalovirus and Epitope in his Cytotoxic T cell study. His Major histocompatibility complex study integrates concerns from other disciplines, such as CTL* and Antigen presentation. As part of the same scientific family, Hans-Georg Rammensee usually focuses on CD8, concentrating on Human leukocyte antigen and intersecting with Amino acid.
Immunology, Antigen, Human leukocyte antigen, T cell and Epitope are his primary areas of study. Hans-Georg Rammensee combines subjects such as Cytotoxic T cell and Transplantation with his study of Immunology. His Cytotoxic T cell study combines topics from a wide range of disciplines, such as Major histocompatibility complex and Cell biology.
His research in Antigen intersects with topics in Molecular biology, Cancer research and Cancer, Immunotherapy. Hans-Georg Rammensee combines subjects such as Myeloid leukemia, Computational biology, Immunogenicity and Cancer immunotherapy with his study of Human leukocyte antigen. His Epitope research includes themes of MHC class I, Tumor antigen and Virology.
His primary areas of investigation include Antigen, T cell, Immune system, Human leukocyte antigen and Cancer research. The study incorporates disciplines such as Computational biology and Peptide in addition to Antigen. To a larger extent, Hans-Georg Rammensee studies Immunology with the aim of understanding T cell.
Hans-Georg Rammensee has researched Immune system in several fields, including Inflammation, Antibody, Radiation therapy and Vaccination. His Cancer research research integrates issues from Cancer, Immunotherapy and Antigen presentation. The CD8 study combines topics in areas such as Cytotoxic T cell, Major histocompatibility complex, Molecular biology and T-cell receptor.
Hans-Georg Rammensee mainly investigates Antigen, T cell, Human leukocyte antigen, CD8 and Computational biology. His Antigen research includes elements of Cancer and Cancer research. His T cell research is multidisciplinary, incorporating elements of Heterologous, Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2, Peripheral blood mononuclear cell and Immunotherapy.
His Human leukocyte antigen study is concerned with the field of Immunology as a whole. His Immunology research is multidisciplinary, incorporating perspectives in Extracellular and Intracellular. His research investigates the link between CD8 and topics such as Major histocompatibility complex that cross with problems in T-cell receptor, Integrin, Signal transduction and Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Identification of HLA-A2–Restricted T-Cell Epitopes Derived From the MUC1 Tumor Antigen for Broadly Applicable Vaccine Therapies
Peter Brossart;Kathrin S. Heinrich;Gernot Stuhler;Lars Behnke.
The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor.
Harpreet Singh-Jasuja;Hans Ulrich Scherer;Norbert Hilf;Danièle Arnold-Schild.
European Journal of Immunology (2000)
Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2).
Andrew Godkin;Thomas Friede;Miles Davenport;Stefan Stevanovic.
International Immunology (1997)
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Stefan Löb;Alfred Königsrainer;Hans-Georg Rammensee;Gerhard Opelz.
Nature Reviews Cancer (2009)
Cleavage motifs of the yeast 20S proteasome β subunits deduced from digests of enolase 1
Alexander K. Nussbaum;Tobias P. Dick;Wieland Keilholz;Markus Schirle.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Cross-Presentation of Glycoprotein 96–Associated Antigens on Major Histocompatibility Complex Class I Molecules Requires Receptor-Mediated Endocytosis
Harpreet Singh-Jasuja;René E.M. Toes;Pieter Spee;Christian Münz.
Journal of Experimental Medicine (2000)
The HLA-A*6601 peptide motif: prediction by pocket structure and verification by peptide analysis
Florian H. Seeger;Markus Schirle;John Gatfield;Danièle Arnold.
Her-2/neu-derived Peptides Are Tumor-associated Antigens Expressed by Human Renal Cell and Colon Carcinoma Lines and Are Recognized by in Vitro Induced Specific Cytotoxic T Lymphocytes
Peter Brossart;Gernot Stuhler;Thomas Flad;Stefan Stevanovic.
Cancer Research (1998)
Protective Immunity Does Not Correlate with the Hierarchy of Virus-specific Cytotoxic T Cell Responses to Naturally Processed Peptides
Awen Gallimore;Tilman Dumrese;Hans Hengartner;Rolf M. Zinkernagel.
Journal of Experimental Medicine (1998)
Tumor-associated MICA is shed by ADAM proteases.
Inja Waldhauer;Dennis Goehlsdorf;Friederike Gieseke;Toni Weinschenk.
Cancer Research (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: